Showing results (51-60 of 6,003) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|January 12, 2011
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signalsFrancesco Marampon, Giovanni Luca Gravina, Agnese Di Rocco, et al.
Molecular Cancer Therapeutics|January 12, 2011
Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin-mediated b16.f10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivoPeter Jantscheff, Martin Schlesinger, Juliane Fritzsche, et al.
Molecular Cancer Therapeutics|September 3, 2010
Molecular therapy targeting Sonic hedgehog and hepatocyte growth factor signaling in a mouse model of medulloblastomaValerie Coon, Tamara Laukert, Carolyn A Pedone, et al.
Molecular Cancer Therapeutics|November 16, 2010
A small-molecule inhibitor of MDMX activates p53 and induces apoptosisHongbo Wang, Xujun Ma, Shumei Ren, et al.
Molecular Cancer Therapeutics|December 17, 2010
Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cellsKirsi Ketola, Paula Vainio, Vidal Fey, et al.
Molecular Cancer Therapeutics|December 17, 2010
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutationJin Kyung Rho, Yun Jung Choi, Byung-Suk Jeon, et al.
Molecular Cancer Therapeutics|December 17, 2010
Chemoprevention of chemically induced skin tumorigenesis by ligand activation of peroxisome proliferator-activated receptor-beta/delta and inhibition of cyclooxygenase 2Bokai Zhu, Robert Bai, Mary J Kennett, et al.
Molecular Cancer Therapeutics|December 9, 2010
Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazineSandeep Singh, Rebecca Davis, Vignesh Alamanda, et al.
Molecular Cancer Therapeutics|January 22, 2011
Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cellsLi Liu, Hong Shi, Yuan Liu, et al.
Molecular Cancer Therapeutics|January 22, 2011
Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural frameworkYi-Bing Huang, Xiao-Fei Wang, Hong-Ye Wang, et al.
Pageof 601